Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Multi-Center, Randomized, Placebo Controlled Safety, Tolerability & Efficacy Trial Of A New Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment Of Mild-To-Moderate Plaque Psoriasis In Adults

NCT03000608 is registered in ClinicalTrials.gov with Santalis Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03000608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03000608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Multi-Center, Randomized, Placebo Controlled Safety, Tolerability & Efficacy Trial Of A New Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment Of Mild-To-Moderate Plaque Psoriasis In Adults
Lead sponsor
Santalis Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 17, 2017
Completion date
December 14, 2017
Enrollment
69 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis